1996
DOI: 10.1016/s1081-1206(10)63502-8
|View full text |Cite
|
Sign up to set email alerts
|

Once Daily Mometasone Furoate Aqueous Nasal Spray Is As Effective as Twice Daily Beclomethasone Dipropionate for Treating Perennial Allergic Rhinitis Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
0

Year Published

2003
2003
2016
2016

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 66 publications
(28 citation statements)
references
References 13 publications
0
28
0
Order By: Relevance
“…The proportion of patients with adverse events was similar for MFNS and placebo (OR = 0.99; 95% CI: 0.81-1.20; P = 0.91). Heterogeneity was not significant (17,18,20,21,24,49,51,52,54) (Fig. 5).…”
Section: Discussionmentioning
confidence: 91%
See 3 more Smart Citations
“…The proportion of patients with adverse events was similar for MFNS and placebo (OR = 0.99; 95% CI: 0.81-1.20; P = 0.91). Heterogeneity was not significant (17,18,20,21,24,49,51,52,54) (Fig. 5).…”
Section: Discussionmentioning
confidence: 91%
“…Consequently, 17 evaluations on TNSS were included (10 interventional studies comparing MFNS vs placebo for the treatment of AR in 1878 adults (17-19, 21, 49-54); one RCT evaluating 271 children (24); five studies assessing postchallenge effects on TNSS in 634 participants (17,(55)(56)(57)(58) and one study commenced treatment 4 weeks preseasonally (n = 215) (20). Data on the individual nasal symptom scores were available in seven studies including 1582 subjects (19,21,(49)(50)(51)(52)54). Nonnasal symptom scores were assessed in four studies (n = 1009) (21, 49, 51, 52) and nasal airflow in three studies (n = 271) (17,50,53).…”
Section: Search Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…We performed an ad hoc analysis of data from 4 similarly designed phase 3 clinical trials of mometasone furoate nasal spray (MFNS) in subjects with PAR, with a particular interest in time to symptom suppression and to symptom recurrence [4,5,6]. Details of the studies are shown in table 1.…”
Section: Methodsmentioning
confidence: 99%